LUCY
LUCY
NASDAQ · Health Care

Innovative Eyewear Inc

$1.03
-0.06 (-5.09%)
Financial Highlights (FY 2026)
Revenue
5.85M
Net Income
-27,769,057
Gross Margin
13.1%
Profit Margin
-474.6%
Rev Growth
+33.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 13.1% 13.1% 62.7% 62.7%
Operating Margin -484.2% -435.8% 15.5% 16.4%
Profit Margin -474.6% -450.9% 9.6% 11.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.85M 4.39M 2.98M 2.71M
Gross Profit 769.4K 576.9K 1.87M 1.70M
Operating Income -28,330,348 -19,119,161 461.5K 445.9K
Net Income -27,769,057 -18,740,365 285.3K 317.3K
Gross Margin 13.1% 13.1% 62.7% 62.7%
Operating Margin -484.2% -435.8% 15.5% 16.4%
Profit Margin -474.6% -450.9% 9.6% 11.7%
Rev Growth +33.4% +33.4% +8.5% -7.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.44M 1.22M
Total Equity 3.52M 3.66M
D/E Ratio 0.41 0.33
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,377,423 -19,502,513 526.6K 581.1K
Free Cash Flow 264.2K 181.0K